Global Futures: Ming Li is developing personalized cancer vaccines

Wednesday, January 24, 2024

Cancer is the leading cause of death in Canada. According to the Canadian Cancer Society, an estimated 230,000 people are diagnosed with cancer every year.  

Dr. Ming Li, a Canada Research Chair in Bioinformatics and University Professor in the David R. Cheriton School of Computer Science, is using deep learning technology to make personalized cancer vaccines accessible to everyone. Li initially began doing cancer research when his wife, Jessie W. H. Zou, was diagnosed with breast cancer. Though she died in 2010, her legacy continues in Li’s research. 

His team’s software, DeepImmu, replaces a lot of lab work with AI, and takes the cutting-edge treatment from a million-dollar specialty treatment to a much more affordable process that the average patient can access.  

Read the full story, which is part of the 2024 Global Futures, to learn more.